BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Au KP, Chok KSH. Immunotherapy after liver transplantation: Where are we now? World J Gastrointest Surg 2021; 13(10): 1267-1278 [PMID: 34754394 DOI: 10.4240/wjgs.v13.i10.1267]
URL: https://www.wjgnet.com/1948-5182/full/v13/i10/1267.htm
Number Citing Articles
1
Coskun Ozer Demirtas, Feyza Gunduz. Programmed Cell Death 1 and Hepatocellular Carcinoma: An Epochal StoryJournal of Gastrointestinal Cancer 2021; 52(4): 1217 doi: 10.1007/s12029-021-00758-z
2
Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Thomas Talbot, Alessandra Gennari, Mark R. Openshaw, Coskun O. Demirtas, Alessio Cortellini, David J. Pinato. New Frontiers in the Medical Therapy of Hepatocellular CarcinomaChemotherapy 2022;  doi: 10.1159/000521837
3
Kathrine S Rallis, Dimitrios Makrakis, Ioannis A Ziogas, Georgios Tsoulfas. Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advancesWorld Journal of Clinical Oncology 2022; 13(6): 448-472 doi: 10.5306/wjco.v13.i6.448
4
Anthony C. Bejjani, Richard S. Finn. Hepatocellular Carcinoma: Pick the Winner—Tyrosine Kinase Inhibitor Versus Immuno-oncology Agent–Based CombinationsJournal of Clinical Oncology 2022;  doi: 10.1200/JCO.21.02605
5
Sai Swarupa R Vulasala, Nirmal K Onteddu, Sindhu P Kumar, Chandana Lall, Priya Bhosale, Mayur K Virarkar. Advances and effectiveness of the immunotherapy after liver transplantationWorld Journal of Gastrointestinal Surgery 2022; 14(6): 629-631 doi: 10.4240/wjgs.v14.i6.629